The heightened levels of these pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and chemokines (IL-8) in the serum of IC/BPS patients not only suggest mast cell activation but also underline the significance of other inflammatory mediators in the pathogenesis of IC/BPS. The gene discussed is TNF; the disease is Bartsocas-Papas syndrome 1.